RPL17 and neoplasm: Key immune-resistance mechanisms within the TME include the reduction of CD8+ T cells, recruitment of immunosuppressive cells such as Treg cells, upregulation of immune checkpoints pathways like PD- 1/PD-L1, and the promotion of tumour neovascularization [81].